Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells

Ryoji Kitamura, Tomosaburo Takahashi, Norio Nakajima, Koji Isodono, Satoshi Asada, Hikaru Ueno, Tomomi Ueyama, Toshikazu Yoshikawa, Hiroaki Matsubara, Hidemasa Oh

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The role of Smads and their specific ligands during cardiomyogenesis in ES cells was examined. Smad2 was activated bimodally in the early and late phases of cardiac differentiation, whereas Smad1 was activated after the middle phase. Nodal and Cripto were expressed in the early stage and then downregulated, whereas transforming growth factor-β and activin were expressed only in the late phase. Suppression of early Smad2 activation by SB-431542 produced complete inhibition of endodermal and mesodermal induction but augmented neuroectodermal differentiation, followed by poor cardiomyogenesis, whereas inhibition during the late phase alone promoted cardiomyogenesis. Inhibitory effect of Smad2 on cardiomyogenesis in the late phase was mainly mediated by transforming growth factor-β, and inhibition of transforming growth factor-β-mediated Smad2 activation resulted in a greater replicative potential in differentiated cardiac myocytes and enhanced differentiation of nonmyocytes into cardiac myocytes. Thus, endogenous Smad2 activation is indispensable for endodermal and mesodermal induction in the early phase. In the late phase, endogenous transforming growth factor-β negatively regulates cardiomyogenesis through Smad2 activation by modulating proliferation and differentiation of cardiac myocytes.

Original languageEnglish
Pages (from-to)78-87
Number of pages10
JournalCirculation Research
Volume101
Issue number1
DOIs
Publication statusPublished - Jul 2007
Externally publishedYes

Fingerprint

Transforming Growth Factors
Embryonic Stem Cells
Cardiac Myocytes
Activins
Down-Regulation
Ligands

Keywords

  • Cardiomyogenesis
  • Differentiation
  • Embryonic stem cells
  • Smad2
  • TGF-β

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells. / Kitamura, Ryoji; Takahashi, Tomosaburo; Nakajima, Norio; Isodono, Koji; Asada, Satoshi; Ueno, Hikaru; Ueyama, Tomomi; Yoshikawa, Toshikazu; Matsubara, Hiroaki; Oh, Hidemasa.

In: Circulation Research, Vol. 101, No. 1, 07.2007, p. 78-87.

Research output: Contribution to journalArticle

Kitamura, R, Takahashi, T, Nakajima, N, Isodono, K, Asada, S, Ueno, H, Ueyama, T, Yoshikawa, T, Matsubara, H & Oh, H 2007, 'Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells', Circulation Research, vol. 101, no. 1, pp. 78-87. https://doi.org/10.1161/CIRCRESAHA.106.147264
Kitamura, Ryoji ; Takahashi, Tomosaburo ; Nakajima, Norio ; Isodono, Koji ; Asada, Satoshi ; Ueno, Hikaru ; Ueyama, Tomomi ; Yoshikawa, Toshikazu ; Matsubara, Hiroaki ; Oh, Hidemasa. / Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells. In: Circulation Research. 2007 ; Vol. 101, No. 1. pp. 78-87.
@article{7803185e35b54766bdbebbbd1abb537b,
title = "Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells",
abstract = "The role of Smads and their specific ligands during cardiomyogenesis in ES cells was examined. Smad2 was activated bimodally in the early and late phases of cardiac differentiation, whereas Smad1 was activated after the middle phase. Nodal and Cripto were expressed in the early stage and then downregulated, whereas transforming growth factor-β and activin were expressed only in the late phase. Suppression of early Smad2 activation by SB-431542 produced complete inhibition of endodermal and mesodermal induction but augmented neuroectodermal differentiation, followed by poor cardiomyogenesis, whereas inhibition during the late phase alone promoted cardiomyogenesis. Inhibitory effect of Smad2 on cardiomyogenesis in the late phase was mainly mediated by transforming growth factor-β, and inhibition of transforming growth factor-β-mediated Smad2 activation resulted in a greater replicative potential in differentiated cardiac myocytes and enhanced differentiation of nonmyocytes into cardiac myocytes. Thus, endogenous Smad2 activation is indispensable for endodermal and mesodermal induction in the early phase. In the late phase, endogenous transforming growth factor-β negatively regulates cardiomyogenesis through Smad2 activation by modulating proliferation and differentiation of cardiac myocytes.",
keywords = "Cardiomyogenesis, Differentiation, Embryonic stem cells, Smad2, TGF-β",
author = "Ryoji Kitamura and Tomosaburo Takahashi and Norio Nakajima and Koji Isodono and Satoshi Asada and Hikaru Ueno and Tomomi Ueyama and Toshikazu Yoshikawa and Hiroaki Matsubara and Hidemasa Oh",
year = "2007",
month = "7",
doi = "10.1161/CIRCRESAHA.106.147264",
language = "English",
volume = "101",
pages = "78--87",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells

AU - Kitamura, Ryoji

AU - Takahashi, Tomosaburo

AU - Nakajima, Norio

AU - Isodono, Koji

AU - Asada, Satoshi

AU - Ueno, Hikaru

AU - Ueyama, Tomomi

AU - Yoshikawa, Toshikazu

AU - Matsubara, Hiroaki

AU - Oh, Hidemasa

PY - 2007/7

Y1 - 2007/7

N2 - The role of Smads and their specific ligands during cardiomyogenesis in ES cells was examined. Smad2 was activated bimodally in the early and late phases of cardiac differentiation, whereas Smad1 was activated after the middle phase. Nodal and Cripto were expressed in the early stage and then downregulated, whereas transforming growth factor-β and activin were expressed only in the late phase. Suppression of early Smad2 activation by SB-431542 produced complete inhibition of endodermal and mesodermal induction but augmented neuroectodermal differentiation, followed by poor cardiomyogenesis, whereas inhibition during the late phase alone promoted cardiomyogenesis. Inhibitory effect of Smad2 on cardiomyogenesis in the late phase was mainly mediated by transforming growth factor-β, and inhibition of transforming growth factor-β-mediated Smad2 activation resulted in a greater replicative potential in differentiated cardiac myocytes and enhanced differentiation of nonmyocytes into cardiac myocytes. Thus, endogenous Smad2 activation is indispensable for endodermal and mesodermal induction in the early phase. In the late phase, endogenous transforming growth factor-β negatively regulates cardiomyogenesis through Smad2 activation by modulating proliferation and differentiation of cardiac myocytes.

AB - The role of Smads and their specific ligands during cardiomyogenesis in ES cells was examined. Smad2 was activated bimodally in the early and late phases of cardiac differentiation, whereas Smad1 was activated after the middle phase. Nodal and Cripto were expressed in the early stage and then downregulated, whereas transforming growth factor-β and activin were expressed only in the late phase. Suppression of early Smad2 activation by SB-431542 produced complete inhibition of endodermal and mesodermal induction but augmented neuroectodermal differentiation, followed by poor cardiomyogenesis, whereas inhibition during the late phase alone promoted cardiomyogenesis. Inhibitory effect of Smad2 on cardiomyogenesis in the late phase was mainly mediated by transforming growth factor-β, and inhibition of transforming growth factor-β-mediated Smad2 activation resulted in a greater replicative potential in differentiated cardiac myocytes and enhanced differentiation of nonmyocytes into cardiac myocytes. Thus, endogenous Smad2 activation is indispensable for endodermal and mesodermal induction in the early phase. In the late phase, endogenous transforming growth factor-β negatively regulates cardiomyogenesis through Smad2 activation by modulating proliferation and differentiation of cardiac myocytes.

KW - Cardiomyogenesis

KW - Differentiation

KW - Embryonic stem cells

KW - Smad2

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=34447622302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447622302&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.106.147264

DO - 10.1161/CIRCRESAHA.106.147264

M3 - Article

VL - 101

SP - 78

EP - 87

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -